Lipitor Safer Than Zocor — Pfizer Study

Patients who switched from the cholesterol-cutting drug Lipitor to the competitor simvastatin increased their risk of suffering heart attacks and strokes, according to a study that Pfizer unveiled on Wednesday.
CNN Money